119th Congress · introduced in the Senate · Dec 18, 2025
NIH Clinical Trial Integrity Act
Official title from Congress.gov
Latest action (Dec 18, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
2 citations.
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$70,000
Spent on own lobbying
…on and Awareness Requires Learning Young Act of 2009. H.Res.806 - Supporting the recognition of October 2025 as National Breast Cancer Awareness Month H.R.6867/S.3564 - Clinical Trial Integrity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health,…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PATIENT ACCESS NETWORK FOUNDATION · lobbying firm or registrant: VENABLE LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 6, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
…remium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing